XML 27 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities:    
Net loss $ (3,307,989) $ (2,669,438)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 4,628,732 4,057,956
Stock compensation 298,546 390,342
Gain on sale of real estate (2,426,004) (1,026,371)
Bad debt expense 95,790 49,908
Income attributable to noncontrolling interests 1,709,127 875,264
Other assets 146,347 (124,080)
Accounts payable and accrued liabilities 1,918,405 83,560
Asset impairments 950,000 1,500,000
Net cash provided by operating activities 4,012,954 3,137,141
Cash flows from investing activities:    
Real estate acquisitions (17,509,525) (5,321,059)
Building and tenant improvements (1,978,375) [1] (2,286,807) [1]
Gain on dissolution of partnership assets (302,831) 0
Deferred leasing costs (336,632) (645,089)
Proceeds received sale of real estate assets 13,397,427 8,450,159
Restricted cash (8,778,384) (324,472)
Net cash used in investing activities (15,508,320) (127,268)
Cash flows from financing activities:    
Proceeds from mortgage notes payable 22,717,173 23,052,635
Repayment of mortgage notes payable (12,866,440) (26,284,654)
Proceeds from issuance of mandatorily redeemable preferred stock 15,000,000 0
Deferred financing costs related to issuance of mandatorily redeemable preferred stock (2,724,252) 0
Repurchase of common stock - related parties (165,018) 0
Repurchase of common stock (47,194) (34,172)
Debt issuance costs (575,020) (349,743)
Redemption of Series 6.3% preferred stock (1,649,266) 0
(Distributions paid) contributions received in excess of contributions received/(distributions paid) from/to noncontrolling interests (2,671,269) 1,997,829
Dividends paid (3,837,162) (3,527,122)
Net cash provided by (used in) financing activities 13,181,552 (5,145,227)
Net decrease in cash and cash equivalents 1,686,186 (2,135,354)
Cash and cash equivalents:    
Beginning of period 10,207,001 10,746,536
Ending of period 11,893,187 8,611,182
Supplemental disclosure of cash flow information:    
Interest paid - mortgage notes payable 3,936,607 3,857,943
Non-cash financing activities:    
Conversion of partnership interests into common stock 165,018 333,269
Reinvestment of cash dividend 2,647,443 2,010,605
Accrual of dividends payable 963,446 1,204,753
Stock issued for purchase of NTR, Inc. $ 0 $ 1,900,000
[1] Total consolidated capital expenditures are equal to the same amounts disclosed for total reportable segments.